{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:44:01Z","timestamp":1793065441339,"version":"4.5.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,8,18]],"date-time":"2018-08-18T00:00:00Z","timestamp":1534550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1,1]]},"DOI":"10.1093\/neuonc\/noy137","type":"journal-article","created":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T15:33:43Z","timestamp":1534520023000},"page":"26-36","source":"Crossref","is-referenced-by-count":213,"title":["Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group"],"prefix":"10.1093","volume":"21","author":[{"given":"Raymond Y","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Radiology, Brigham and Women\u2019s Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenya Linda","family":"Bi","sequence":"additional","affiliation":[{"name":"Center for Skull Base and Pituitary Surgery, Department of Neurosurgery, Brigham and Women\u2019s Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Weller","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital Zurich, Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kaley","sequence":"additional","affiliation":[{"name":"Neuro-Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaishri","family":"Blakeley","sequence":"additional","affiliation":[{"name":"The Johns Hopkins Hospital, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Dunn","sequence":"additional","affiliation":[{"name":"Center for Skull Base and Pituitary Surgery, Department of Neurosurgery, Brigham and Women\u2019s Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evanthia","family":"Galanis","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Preusser","sequence":"additional","affiliation":[{"name":"Clinical Division of Oncology, Department of Medicine I, Comprehensive Cancer Centre, Medical University Vienna\u2013General Hospital, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"McDermott","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, University of California San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leland","family":"Rogers","sequence":"additional","affiliation":[{"name":"Radiation Oncology, Barrow Neurological Institute, Phoenix, Arizona, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Raizer","sequence":"additional","affiliation":[{"name":"Medical Neuro-Oncology, Northwestern Medicine, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Schiff","sequence":"additional","affiliation":[{"name":"Departments of Neurology, Neurological Surgery, and Medicine, University of Virginia, Charlottesville, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Soffietti","sequence":"additional","affiliation":[{"name":"Department of Neuro-Oncology, University of Turin and City of Health and Science University Hospital, Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg-Christian","family":"Tonn","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Ludwig-Maximilians-Universit\u00e4t, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Vogelbaum","sequence":"additional","affiliation":[{"name":"Rose Ella Burkhardt Brain Tumor and Neuro Oncology Center, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Weber","sequence":"additional","affiliation":[{"name":"Paul Scherrer Institut, Villigen, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Reardon","sequence":"additional","affiliation":[{"name":"Center of Neuro-Oncology, Dana-Farber\/Brigham and Women\u2019s Cancer Center, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick Y","family":"Wen","sequence":"additional","affiliation":[{"name":"Center of Neuro-Oncology, Dana-Farber\/Brigham and Women\u2019s Cancer Center, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,8,18]]},"reference":[{"key":"key\n\t\t\t\t2018122123582457100_CIT0001","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/nou223","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007\u20132011","volume":"16","author":"Ostrom","year":"2014","journal-title":"Neuro Oncol"},{"issue":"12","key":"key\n\t\t\t\t2018122123582457100_CIT0002","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(06)70625-1","article-title":"Histological classification and molecular genetics of meningiomas","volume":"5","author":"Riemenschneider","year":"2006","journal-title":"Lancet Neurol"},{"issue":"3","key":"key\n\t\t\t\t2018122123582457100_CIT0003","first-page":"231","article-title":"The histopathological spectrum of human meningiomas","volume":"5","author":"Backer-Gr\u00f8ndahl","year":"2012","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"key\n\t\t\t\t2018122123582457100_CIT0004","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/bpa.12174","article-title":"Mitotic index is an independent predictor of recurrence-free survival in meningioma","volume":"25","author":"Olar","year":"2015","journal-title":"Brain Pathol"},{"issue":"5","key":"key\n\t\t\t\t2018122123582457100_CIT0005","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.3171\/FOC\/2008\/24\/5\/E3","article-title":"Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria","volume":"24","author":"Pearson","year":"2008","journal-title":"Neurosurg Focus"},{"key":"key\n\t\t\t\t2018122123582457100_CIT0006","volume-title":"World Health Organization Histological Classification of Tumours of the Central Nervous System","author":"Louis","year":"2016"},{"issue":"1","key":"key\n\t\t\t\t2018122123582457100_CIT0007","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3171\/2014.7.JNS131644","article-title":"Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review","volume":"122","author":"Rogers","year":"2015","journal-title":"J Neurosurg"},{"issue":"3","key":"key\n\t\t\t\t2018122123582457100_CIT0008","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11060-010-0349-8","article-title":"Medical therapies for meningiomas","volume":"99","author":"Wen","year":"2010","journal-title":"J Neurooncol"},{"issue":"6","key":"key\n\t\t\t\t2018122123582457100_CIT0009","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/neuonc\/not330","article-title":"Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review","volume":"16","author":"Kaley","year":"2014","journal-title":"Neuro Oncol"},{"issue":"9","key":"key\n\t\t\t\t2018122123582457100_CIT0010","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/S1470-2045(16)30321-7","article-title":"EANO guidelines for the diagnosis and treatment of meningiomas","volume":"17","author":"Goldbrunner","year":"2016","journal-title":"Lancet Oncol"},{"issue":"7","key":"key\n\t\t\t\t2018122123582457100_CIT0011","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1200\/JCO.1990.8.7.1277","article-title":"Response criteria for phase II studies of supratentorial malignant glioma","volume":"8","author":"Macdonald","year":"1990","journal-title":"J Clin Oncol"},{"issue":"2","key":"key\n\t\t\t\t2018122123582457100_CIT0012","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"3","key":"key\n\t\t\t\t2018122123582457100_CIT0013","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.ijrobp.2006.12.073","article-title":"Intensity-modulated radiotherapy for complex-shaped meningioma of the skull base: long-term experience of a single institution","volume":"68","author":"Milker-Zabel","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"key\n\t\t\t\t2018122123582457100_CIT0014","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","article-title":"Updated response assessment criteria for high-grade gliomas: Response Assessment in Neuro-Oncology Working Group","volume":"28","author":"Wen","year":"2010","journal-title":"J Clin Oncol"},{"issue":"6","key":"key\n\t\t\t\t2018122123582457100_CIT0015","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1470-2045(11)70057-2","article-title":"Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas","volume":"12","author":"van den Bent","year":"2011","journal-title":"Lancet Oncol"},{"issue":"6","key":"key\n\t\t\t\t2018122123582457100_CIT0016","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S1470-2045(15)70057-4","article-title":"Response assessment criteria for brain metastases: proposal from the RANO group","volume":"16","author":"Lin","year":"2015","journal-title":"Lancet Oncol"},{"issue":"9","key":"key\n\t\t\t\t2018122123582457100_CIT0017","first-page":"1188","article-title":"Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials","volume":"17","author":"Ellingson","year":"2015","journal-title":"Neuro Oncol"},{"issue":"12","key":"key\n\t\t\t\t2018122123582457100_CIT0018","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1093\/neuonc\/nox112","article-title":"PET imaging in patients with meningioma-report of the RANO\/PET Group","volume":"19","author":"Galldiks","year":"2017","journal-title":"Neuro Oncol"},{"key":"key\n\t\t\t\t2018122123582457100_CIT0019","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.clineuro.2016.12.014","article-title":"Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery","volume":"153","author":"Kim","year":"2017","journal-title":"Clin Neurol Neurosurg"},{"issue":"4","key":"key\n\t\t\t\t2018122123582457100_CIT0020","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1215\/15228517-2008-107","article-title":"Pseudoprogression in boron neutron capture therapy for malignant gliomas and meningiomas","volume":"11","author":"Miyatake","year":"2009","journal-title":"Neuro Oncol"},{"issue":"5","key":"key\n\t\t\t\t2018122123582457100_CIT0021","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1148\/rg.325125002","article-title":"Radiation necrosis in the brain: imaging features and differentiation from tumor recurrence","volume":"32","author":"Shah","year":"2012","journal-title":"Radiographics"},{"issue":"23","key":"key\n\t\t\t\t2018122123582457100_CIT0022","doi-asserted-by":"crossref","first-page":"7412","DOI":"10.1158\/1078-0432.CCR-09-1624","article-title":"Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria","volume":"15","author":"Wolchok","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"15","key":"key\n\t\t\t\t2018122123582457100_CIT0023","doi-asserted-by":"crossref","first-page":"e534","DOI":"10.1016\/S1470-2045(15)00088-1","article-title":"Immunotherapy response assessment in neuro-oncology: a report of the RANO working group","volume":"16","author":"Okada","year":"2015","journal-title":"Lancet Oncol"},{"issue":"5","key":"key\n\t\t\t\t2018122123582457100_CIT0024","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/neuonc\/nox029","article-title":"The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria","volume":"19","author":"Nayak","year":"2017","journal-title":"Neuro Oncol"},{"issue":"1","key":"key\n\t\t\t\t2018122123582457100_CIT0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/RLI.0b013e3181c02ed5","article-title":"Intra- and interobserver variability of linear and volumetric measurements of brain metastases using contrast-enhanced magnetic resonance imaging","volume":"45","author":"Bauknecht","year":"2010","journal-title":"Invest Radiol"},{"issue":"6","key":"key\n\t\t\t\t2018122123582457100_CIT0026","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1227\/01.neu.0000333303.79931.83","article-title":"Three-dimensional volumetrics for tracking vestibular schwannoma growth in neurofibromatosis type II","volume":"62","author":"Harris","year":"2008","journal-title":"Neurosurgery"},{"key":"key\n\t\t\t\t2018122123582457100_CIT0027","article-title":"Radiologic response evaluation of brain metastases: uni-dimensional (1D), W.H.O. RECIST vs bi-dimensional (2D) or 3-dimensional (3D) criteria","author":"Sze","year":"2001","journal-title":"Proc Am Soc Clin Oncol"},{"key":"key\n\t\t\t\t2018122123582457100_CIT0028","article-title":"Influence of metastatic volume on local control and survival assessed by 3D volumetric measurements after radiosurgery in patients with brain metastases and planned observation","volume":"187","author":"van der Weide","year":"2011","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"key\n\t\t\t\t2018122123582457100_CIT0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000177622","article-title":"Analysis of factors associated with volumetric data errors in gamma knife radiosurgery","volume":"87","author":"Yang","year":"2009","journal-title":"Stereotact Funct Neurosurg"},{"issue":"4","key":"key\n\t\t\t\t2018122123582457100_CIT0030","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000101297","article-title":"Prediction of volumetric data errors in patients treated with gamma knife radiosurgery","volume":"85","author":"Pan","year":"2007","journal-title":"Stereotact Funct Neurosurg"},{"issue":"4","key":"key\n\t\t\t\t2018122123582457100_CIT0031","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1158\/1078-0432.CCR-08-1080","article-title":"Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer","volume":"15","author":"Lin","year":"2009","journal-title":"Clin Cancer Res"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/21\/1\/26\/27237321\/noy137.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T10:07:45Z","timestamp":1571738865000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/21\/1\/26\/5076187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,18]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,8,18]]},"published-print":{"date-parts":[[2019,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noy137","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,1]]},"published":{"date-parts":[[2018,8,18]]}}}